|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 412 FIRST STREET SE |
Address2 | SUITE 100 |
| City | WASHINGTON |
State | DC |
Zip Code | 20003 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 12868-3957
|
||||||||
|
6. House ID# 322290245
|
||||||||
| TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Joshua Ian Rosenstein, Vice President and General Counsel |
Date | 04/07/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Develop a strategy with respect to legislation aimed at banning or limiting the use of Bisphenol A. HR 1523, S593, S753. Agriculture Approps HR 2997 & S 1406. S. 1733 Clean Energy Jobs and American Power Act Green Taxis Act of 2009.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracy |
Hammond |
|
|
|
Robert P. |
Hall III |
|
|
|
Andrew |
Wright |
|
|
|
Howard |
Berman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
H.R. 2477Chemical Facility Authorization Act of 2009, H.R. 875-- Food Safety Modernization Act of 2009,
H.R. 2800Imported Food Safety Improvement Act of 2009, H.R. 2749Food Safety Enhancement Act of 2009, H.R.1907Improving Communication with Consumers During Food Recall Act of 2009, H.R. 1332Safe Food Enforcement,
Assessment, Standards, and Targeting Act of 2009, S. 510FDA Food Safety Modernization Act,
S. 893Imported and Domestic Product Safety Act of 2009, S. 1269Food Safety Rapid Response Act, S. 753BPA-Free Kids Act of 2009, S. 593Ban Poisonous Additives Act of 2009, H.R. 1523Ban Poisonous Additives Act of 2009.
Agriculture Approps HR 2997 & S 1406.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracy |
Hammond |
|
|
|
Robert P. |
Hall III |
|
|
|
Andrew |
Wright |
|
|
|
Howard |
Berman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
BPA-Free Kids Act of 2009, To prohibit the manufacture, sale, or distribution in commerce of children's food and beverage containers composed of bisphenol A, and for other purposes H.R. 1523 Ban Poisonous Additives Act of 2009, To ban the use of bisphenol A in food containers, and for other purposes S. 593 Ban Poisonous Additives Act of 2009, To ban the use of bisphenol A in food containers, and for other purposes. Food Safety HR 2749 & S 425. Agriculture Approps HR 2997 & S 1406.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracy |
Hammond |
|
|
|
Robert P. |
Hall III |
|
|
|
Andrew |
Wright |
|
|
|
Howard |
Berman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIN
16. Specific lobbying issues
H.R. 4173 Wall Street Reform and Consumer Protection Act of 2009 Accountability and Transparency in Rating Agencies Act of 2009 Consumer Financial Protection Agency Act of 2009 Corporate and Financial Institution Compensation Fairness Act of 2009
Credit Risk Retention Act of 2009 Dissolution Authority for Large, Interconnected Financial Companies Act of 2009
Federal Insurance Office Act of 2009 Financial Stability Improvement Act of 2009 Investor Protection Act of 2009
Over-the-Counter Derivatives Markets Act of 2009 Private Fund Investment Advisers Registration Act of 2009.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracy |
Hammond |
|
|
|
Robert P. |
Hall III |
|
|
|
Andrew |
Wright |
|
|
|
Howard |
Berman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
5 |
|
||||||
| 2 |
|
6 |
|
||||||
| 3 |
|
7 |
|
||||||
| 4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: http://www.americanchemistry.com/s_acc/sec_directory.asp?CID=250&DID=616
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |